Why Menopause Is a Workplace Issue - Not Just a Personal One
Here is a number worth sitting with.
One million women left the UK workforce in 2023 due to menopausal symptoms.
Not because they wanted to. Not because their skills had diminished or their ambition had faded. Because the gap between what they were experiencing and what their organisations offered in response was too wide to bridge.
That is not a personal health story. Menopause is not a wellbeing issue. It’s a workforce risk. That is an organisational failure - one that carries measurable cost, growing legal exposure, and entirely avoidable consequences.
For the operational and individual side of this - what symptoms actually look like at work, what adjustments help, and how women are navigating this day to day - the menopause at work guide covers the ground that sits beneath the organisational data.
Menopause isn't just a wellbeing issue. It's a retention and performance issue. And the organisations that treat it as the former while ignoring the latter are making an expensive mistake.
The workforce you are losing
Women aged 45 to 55 represent some of the most experienced, senior, and institutionally valuable employees in any organisation. They sit at the intersection of accumulated expertise, leadership capability, and institutional knowledge - the employees who are hardest to replace and most expensive to lose.
Research by Hertility and Riley, drawing on a survey of 2,000 women aged 40 to 60, found that approximately 67% said their symptoms had a mostly negative impact on them at work. The same research estimates that one million women left the workforce in 2023 due to menopausal symptoms. UK Government data confirms that one in ten women who worked during menopause left a job because of their symptoms.
These are not women at the margins of the labour market. Many are in management, senior professional, or leadership roles. When they leave - or when they quietly step back from progression, decline promotion, or reduce their hours - organisations lose the return on years of investment in their development.
The replacement cost of a single senior employee is typically estimated at between 50% and 200% of their annual salary, accounting for recruitment, onboarding, lost productivity during transition, and knowledge transfer. Across a workforce of any meaningful size, the aggregate cost of menopause-related attrition is not a footnote. It is a material business risk.
The hidden productivity drain
Attrition is visible. What organisations rarely measure - and therefore rarely address - is what happens before the resignation letter arrives.
UK Parliament's 'Menopause and the Workplace' report cites 14 million working days lost each year to menopause, equivalent to £1.88 billion in lost productivity. Research by Peppy Health, which examined wider perimenopause impact, puts the total potential business cost at £2.9 billion per annum - the equivalent of 22 million working days lost every year.
But raw absence figures understate the problem significantly. The UK Government's own literature review on menopause and workplace productivity (2024) identifies a pattern that most organisations will recognise when it is named: presenteeism. Women who are at work but not fully functioning. Women who are compensating for cognitive symptoms by working additional unpaid hours outside contracted time. Women who are delivering output that looks normal from the outside while carrying a significant hidden cost.
Some studies suggest that productivity actually increases as symptoms worsen - in part because women compensate by working unpaid outside working hours. That is not a positive finding. It is evidence of a silent tax being levied on a specific cohort of employees, invisible in performance data, unaddressed in management conversations, and entirely unsustainable as a long-term strategy. This is what happens when menopause is treated as a wellbeing issue instead of a workforce risk.
The research is also clear that perception compounds the problem: women report not only a genuine impact on performance but also a felt perception from others of declining capability - which isn't always accurate, but erodes confidence and self-assessment in ways that further affect output.
The leadership blind spot
Most senior leadership teams do not discuss menopause as a business risk. They may have a menopause policy - often drafted by HR, rarely read by management, almost never integrated into line management practice. They may have attended a webinar. They may have signed a pledge.
What they typically have not done is connect the data - on attrition, on absence, on engagement scores among women aged 45 to 55, on the demographic profile of promotion decisions over the past decade - to the specific, addressable cause that links them.
When multiplied across affected staff, the cost of menopause-related absence, attrition and reduced productivity runs into the billions each year in the UK. That cost does not appear in any board report. It is not tracked in any workforce analytics dashboard most organisations currently operate. It is absorbed, invisibly, into general attrition, general absence, and general underperformance - because no one is asking the right question.
The right question is not "do we have a menopause policy?" It is: "what is menopause costing us - and what would it cost to address it properly?"
The answer to the second part of that question is almost always less than the first.
What responsive organisations are doing differently
Data confirms that workplaces offering customised relief programmes, flexible work arrangements and destigmatising health resources report an 80% boost in staff retention and over 50% of menopausal employees increasing their productivity.
These are not complex or expensive interventions. The organisations seeing the strongest return are those that have done three things well.
First, they have trained their line managers. Not just in policy compliance — in how to have a conversation. The gap between a menopause policy and a menopause-supportive culture almost always lives at the line manager level. A manager who knows how to respond, how to ask, and how to facilitate an adjustment request without making it awkward changes the experience of every woman on their team. A manager who doesn't - even with a policy in place - changes nothing.
Second, they have made flexibility genuinely available, not theoretically permitted. The distinction matters. Many organisations have flexible working policies that exist on paper but carry an implicit cultural penalty in practice. In environments where visible presence is equated with commitment, the formal right to flex is undermined by the informal expectation not to use it. Organisations that have addressed this - at a cultural and management behaviour level, not just a policy level - retain significantly more of their experienced female workforce.
Third, they have normalised the conversation. Not through compulsory training or awareness months alone, but through visible leadership behaviour. When senior women speak openly about their experience, when leaders of any gender acknowledge the issue without embarrassment, when line managers ask rather than assume - the friction that prevents disclosure reduces, and the adjustments that actually help become available before women reach breaking point.
The strategic case for acting now
Menopause is not a wellbeing initiative to consider. It is a workforce risk to manage. The Employment Rights Act 2025 has placed menopause support on the legislative agenda for the first time in UK history. From 6 April 2026, employers with 250 or more employees can voluntarily publish Equality Action Plans that include at least one action on menopause support. From spring 2027, this becomes mandatory, with the first compulsory plans due by April 2028.
The organisations that act now are not just getting ahead of compliance. They are building genuine capability - in management practice, in data collection, in cultural normalisation - that cannot be retrofitted quickly when a deadline arrives. The organisations that wait will face a harder task: implementing structural change under legal pressure, without the institutional readiness that voluntary early adoption would have built.
Menopause support is also, increasingly, a talent differentiator. As awareness grows among the women most affected, the question "what does this organisation do about menopause?" is becoming part of how experienced female candidates assess whether a workplace is one they want to join and stay in. The employers with a credible, visible answer to that question have a meaningful advantage in the competition for experienced talent.
Where to go from here
If you are an HR leader, senior manager, or anyone with influence over workplace policy, the right next step is not another awareness webinar. It is a structured assessment of what your organisation currently offers, what gaps exist, and what the Employment Rights Act 2025 will require you to document and publish.
If you need the operational detail behind this, what managers should actually do, what employees can ask for and how the legal framework applies, these are the next steps:
Menopause Workplace Adjustments: What You Can Ask For (UK Guide)
Menopause at Work: How to Navigate Your Career with Confidence
If you’re responsible for people, performance, or retention, this is already affecting your organisation - whether you’re measuring it or not.
I work with organisations to translate this into practical action: manager training, policy alignment and menopause-aware workplace strategy.
→ Get in touch to discuss sessions, training, or organisational support
References
Hertility and Riley. (2023). The Red Paper: Women's Health and the Workplace.
UK Parliament. (2022). Menopause and the Workplace: Fifth Report of Session 2021–22. House of Commons Women and Equalities Committee.
UK Government. (2024). Menopause and Workplace Productivity. gov.uk
UK Government. (2025). Menopause in the Workplace Literature Review.
UK Government / Government Equalities Office. (4 March 2026). Government launches landmark gender pay gap and menopause action plans. gov.u
British Safety Council. (2023). Navigating the Menopause Maze: Why Employers Must Act.
CIPD. (2023). Menopause in the Workplace: Employee Experiences in 2023.
Steffan B, Potočnik K. (2023). Thinking outside Pandora's Box: revealing differential effects of coping with physical and psychological menopause symptoms on work performance. Work, Aging and Retirement. https://doi.org/10.1177/00187267221089469
D'Angelo S, et al. (2022). Impact of menopausal symptoms on work: findings from Women in the Health and Employment after Fifty (HEAF) Study. Int J Environ Res Public Health. PMID: 36612616
Employment Rights Act 2025. UK Government Legislation.
